H7N9 and Influenza A RNA Detection Qualitative Test
Test Name: H7N9 and Influenza A RNA Detection Qualitative Test
Components: Sputum; throat and nasal swabs in viral transport medium, or lung tissues, Cell Cultures etc.
Price: 1770.0 AED
Sample Condition: Sputum; throat and nasal swabs in viral transport medium, or lung tissues, Cell Cultures etc.
Report Delivery: 4th Working Day Email: 48 hours. On phone: 36 hours
Method: Real Time PCR
Test Type: Viral
Doctor: Physician
Test Department: Genetics
Pre Test Information: Need to sign Consent document and bring any clinical history of patient for H7N9 & Influenza A (RNA Detection) Qualitative Test
Test Details
The H7N9 & Influenza A (RNA Detection) Qualitative Test is a diagnostic test used to detect the presence of H7N9 and Influenza A viruses in a patient’s respiratory samples. It is a molecular test that utilizes the reverse transcription-polymerase chain reaction (RT-PCR) technique to amplify and detect specific RNA sequences of the viruses.
The test involves collecting a respiratory sample, such as a nasal or throat swab, from the patient. The sample is then processed in the laboratory, where the RNA is extracted and converted into complementary DNA (cDNA) using reverse transcription. The cDNA is then amplified using PCR with specific primers targeting the H7N9 and Influenza A RNA sequences.
If the H7N9 or Influenza A viruses are present in the sample, the PCR amplification will generate a positive result, indicating the presence of the viruses. The test can differentiate between H7N9 and other subtypes of Influenza A viruses.
The H7N9 & Influenza A (RNA Detection) Qualitative Test is highly sensitive and specific, providing rapid and accurate results. It is primarily used in outbreak investigations, surveillance programs, and clinical settings to diagnose and monitor H7N9 and Influenza A infections. Early detection of these viruses is crucial for timely treatment and containment of outbreaks.
| Test Name | H7N9 and Influenza A RNA Detection Qualitative Test |
|---|---|
| Components | |
| Price | 1770.0 AED |
| Sample Condition | Sputum; throat and nasal swabs in viral transport medium, or lung tissues, Cell Cultures etc. |
| Report Delivery | 4th Working Day Email : 48 hours.On phone : 36 hours |
| Method | Real Time PCR |
| Test type | Viral |
| Doctor | Physician |
| Test Department: | Genetics |
| Pre Test Information | Need to sign Consent document and bring any clinical history of patient forH7N9 & Influenza A (RNA Detection) QualitativeTest |
| Test Details |
The H7N9 & Influenza A (RNA Detection) Qualitative Test is a diagnostic test used to detect the presence of H7N9 and Influenza A viruses in a patient’s respiratory samples. It is a molecular test that utilizes the reverse transcription-polymerase chain reaction (RT-PCR) technique to amplify and detect specific RNA sequences of the viruses. The test involves collecting a respiratory sample, such as a nasal or throat swab, from the patient. The sample is then processed in the laboratory, where the RNA is extracted and converted into complementary DNA (cDNA) using reverse transcription. The cDNA is then amplified using PCR with specific primers targeting the H7N9 and Influenza A RNA sequences. If the H7N9 or Influenza A viruses are present in the sample, the PCR amplification will generate a positive result, indicating the presence of the viruses. The test can differentiate between H7N9 and other subtypes of Influenza A viruses. The H7N9 & Influenza A (RNA Detection) Qualitative Test is highly sensitive and specific, providing rapid and accurate results. It is primarily used in outbreak investigations, surveillance programs, and clinical settings to diagnose and monitor H7N9 and Influenza A infections. Early detection of these viruses is crucial for timely treatment and containment of outbreaks. |
